Evid Invest
Holders — by stockHoldings — by fund

SECTORAL ASSET MANAGEMENT INC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001274413

$157.4M

disclosed book value

78

positions

13.1%

largest position share

Positions, as of 2026-09-30

top 78 of 78 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1APMDAPNIMED INC942,208$20.6M13.1%
2CTNMCONTINEUM THERAPEUTICS689,587$9.3M5.9%
3SISHOULDER INNOVATIONS430,420$8.1M5.2%
4LLYELI LILLY & CO6,664$7.7M4.9%
5JNJJOHNSON & JOHNSON22,758$6.0M3.8%
6VRTXVERTEX PHARMA7,532$3.9M2.5%
7GILDGILEAD SCIENCES INC24,655$3.7M2.3%
8AMGNAMGEN INC7,860$3.3M2.1%
9ABBVABBVIE INC12,300$3.2M2%
10DXCMDEXCOM INC37,231$3.2M2%
11SMMTSUMMIT THERAPEUTICS177,180$3.0M1.9%
12RCUSARCUS BIOSCIENCES115,933$3.0M1.9%
13MRKMERCK & CO INC20,460$3.0M1.9%
14BNTXBIONTECH SE30,185$3.0M1.9%
15ORKAORUKA THERAPEUTICS INC35,349$2.9M1.9%
16AVTXAVALO THERAPEUTICS INC177,294$2.7M1.7%
17INSMINSMED INC23,706$2.7M1.7%
18AVBPARRIVENT BIOPHARMA87,343$2.6M1.7%
19TNGXTANGO THERAPEUTICS INC105,757$2.6M1.7%
20ARGXARGENX SE2,676$2.6M1.6%
21IRTCIRHYTHM HOLDINGS INC22,570$2.6M1.6%
22ATECALPHATEC HLDGS INC246,150$2.5M1.6%
23CBIOCRESCENT BIOPHARMA INC.167,600$2.4M1.6%
24BRVEBRAVEHEART BIO INC119,743$2.4M1.5%
25ISRGINTUITIVE SURGIC INC5,869$2.4M1.5%
26UNHUNITEDHEALTH GRP INC6,208$2.3M1.4%
27REGNREGENERON PHARMCTCLS2,869$2.2M1.4%
28SYKSTRYKER CORP7,829$2.2M1.4%
29DHRDANAHER CORP9,597$2.1M1.4%
30ROIVROIVANT SCIENCES LTD58,100$2.1M1.4%
31IMTXIMMATICS NV225,985$2.0M1.3%
32TMOTHERMO FISHER SCIENTIFIC2,908$2.0M1.2%
33IQVIQVIA HOLDINGS INC7,014$1.9M1.2%
34ALNYALNYLAM PHARMACUETCL7,385$1.8M1.2%
35ABTABBOTT LABS18,080$1.8M1.1%
36TECXTECTONIC THERAPEUTIC72,592$1.7M1.1%
37PFEPFIZER INC57,500$1.6M1%
38QUREUNIQURE N.V.62,425$1.5M1%
39UTHRUNITED THERAPEUTICS2,695$1.5M0.9%
40ABVXABIVAX SA14,561$1.4M0.9%
41TMDXTRANSMEDICS GROUP INC15,950$1.3M0.8%
42PLSEPULSE BIOSCIENCES INC26,170$1.3M0.8%
43CVSCVS HEALTH CORP13,041$1.1M0.7%
44MRNAMODERNA INC5,300$1.0M0.6%
45CYTKCYTOKINETICS INC15,289$1.0M0.6%
46MDTMEDTRONIC PLC11,100$965,8110.6%
47VERAVERA THERAPEUTICS28,573$922,6220.6%
48ELVELEVANCE HEALTH INC2,006$779,9730.5%
49BMYBRISTOL MYERS SQUIBB12,061$752,6060.5%
50CNCCENTENE CORP DEL12,040$747,9250.5%
51BSXBOSTON SCIENTIFIC14,730$642,9650.4%
52NKTRNEKTAR THERAPEUTICS10,111$612,1710.4%
53EWEDWARDS LIFESCIENCES6,804$587,3210.4%
54ASNDASCENDIS PHARMA A/S2,570$585,5230.4%
55ILMNILLUMINA INC2,132$583,4860.4%
56BMRNBIOMARIN PHARMAC9,450$567,0000.4%
57RVMDREVOLUTION MEDICINES2,760$566,5180.4%
58PTCTPTC THERAPEUTICS INC8,570$555,1650.4%
59HUMHUMANA INC1,255$478,8700.3%
60RPRXROYALTY PHARMA PLC7,200$420,1920.3%
61BIIBBIOGEN INC1,850$417,8780.3%
62GMABGENMAB A/S9,900$353,1830.2%
63GHGUARDANT HEALTH INC1,980$353,1530.2%
64IONSIONIS PHARMACEUTICAL7,200$321,4800.2%
65TEMTEMPUS AI INC3,880$317,7720.2%
66ORICORIC PHARMACEUTICALS23,500$316,5450.2%
67INCYINCYTE CORPORATION2,350$285,1730.2%
68AXSMAXSOME THERAPEUTIC1,500$276,5850.2%
69NAMSNEWAMSTERDAM PHARMA COMPANY9,500$231,0400.1%
70ARDXARDELYX INC56,100$191,8620.1%
71CRBPCORBUS PHARMACEUTICALS HLDGS28,000$190,9600.1%
72KURAKURA ONCOLOGY INC17,050$182,6060.1%
73SPRYARS PHARMACEUTICALS40,300$173,6930.1%
74NBIXNEUROCRINE BIOSCIENCES1,150$163,1160.1%
75ALXOALX ONCOLOGY HLDGS INC90,000$125,1000.1%
76PALIPALISADE BIO INC88,000$118,8000.1%
77EYPTEYEPOINT INC23,700$77,4990%
78ENGNENGENE THERAPEUTICS INC21,700$43,4000%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.